首页|UPLC-ESI-MS/MS法测定替格瑞洛中三环已基膦的含量

UPLC-ESI-MS/MS法测定替格瑞洛中三环已基膦的含量

扫码查看
含膦物质具有潜在基因毒性,在微量的水平下可直接造成DNA损伤,进而引发癌症,威胁人类健康,因此,需对药物中该类杂质进行严格控制。本研究建立一种方法用于替格瑞洛中的三环己基膦的检测。使三环己基膦与过氧化氢反应衍生成为三环己基氧膦;采用Agilent Poroshell 120 EC-C18色谱柱(100 mm×4。6 mm,2。7 μm);流动相为 0。1%甲酸-0。1%甲酸甲醇(体积比 5∶95);流速为 0。5 mL/min,柱温30 ℃;采用电喷雾离子源正离子扫描,以多反应监测模式采集定量离子对297。2→83对三环己基氧膦进行检测。三环己基氧膦在浓度为1。45~28。90 ng/mL范围内与峰面积呈现良好的线性关系(r=0。999 8);定量限为0。14 ng/mL;检测限为0。072 ng/mL;平均加样回收率为99。5%,RSD为5。4%(n=9)。本方法以过氧化氢为氧化剂将三环基膦衍生氧化成为更稳定的三环己基氧膦后采用UPLC-ESI-MS/MS测定,该方法专属性强、灵敏度高、准确度好、分析时间短,可用于替格瑞洛中三环己基膦的检测,有助于提高抗血小板药物替格瑞洛的临床安全性。
Determination of Tricyclohexylphosphine in the Intermediate of Ticagrelor with Derivatization Pretreatment by UPLC-ESI-MS/MS
Substances containing phosphine have potential genotoxicity and can directly cause DNA damage at trace levels,leading to cancer and posing a threat to human health.Therefore,strict control of such impurities in drugs is necessary.In this study,a method was established for the detection of tricyclohexylphosphine in ticagrelor.Tricyclohexylphosphine was derivatized into tricyclohexyloxophosphine after reaction with hydrogen peroxide.An Agilent Poroshell 120 EC-C18 chromatographic column(100 mm×4.6 mm,2.7 μm)was used.The mobile phase was 0.1%formic acid-0.1%formic acid methanol(5∶95),the flow rate was 0.5 mL/min,and the column temperature was 30 ℃.Electrospray ionization source(ESI)positive ion scanning was used to collect quantitative ion pairs 297.2→83 for the detection of tricyclohexyloxophosphine in the multi-reaction monitoring mode(MRM).Tricyclohexylphosphine exhibited a good linear relationship with peak area in the concentration range of 1.45~28.90 ng/mL(r=0.999 8).The limit of quantitation was 0.14 ng/mL,and the limit of detection was 0.072 ng/mL.The average sample recovery rate was 99.5%,and the RSD was 5.4%(n=9).This method could be used for the detection of tricyclohexylphosphine in Ticagrelor by simple pretreatment to derive tricyclohexyloxophosphine,which was more stable,specific,sensitive,accurate,and short in analysis time,which was expected to improve the clinical safety of the drug Ticagrelor.

genotoxic impuritiestricyclohexylphosphinederivatizationUPLC-ESI-MS/MS

徐淑媛、王玉如、卢忠秋、刘晓敏、穆双双、兰公剑

展开 >

南京正大天晴制药有限公司,江苏南京 210046

基因毒杂质 三环己基膦 衍生 超高效液相色谱-质谱联用

2024

山东化工
山东省化工研究院 山东省化工信息中心

山东化工

影响因子:0.249
ISSN:1008-021X
年,卷(期):2024.53(16)